ANI Pharmaceuticals, Inc. (ANIP)
73.25
+0.42
(+0.58%)
USD |
NASDAQ |
Aug 31, 16:00
73.34
+0.09
(+0.12%)
After-Hours: 20:00
ANI Pharmaceuticals Total Long Term Debt (Quarterly) : 610.49M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 610.49M |
| March 31, 2026 | 613.76M |
| December 31, 2025 | 626.36M |
| September 30, 2025 | 631.58M |
| June 30, 2025 | 646.41M |
| March 31, 2025 | 647.67M |
| December 31, 2024 | 648.94M |
| September 30, 2024 | 650.21M |
| June 30, 2024 | 310.09M |
| March 31, 2024 | 310.31M |
| December 31, 2023 | 315.33M |
| September 30, 2023 | 310.73M |
| June 30, 2023 | 286.09M |
| March 31, 2023 | 286.31M |
| December 31, 2022 | 287.90M |
| September 30, 2022 | 288.21M |
| June 30, 2022 | 287.94M |
| March 31, 2022 | 287.16M |
| December 31, 2021 | 288.36M |
| September 30, 2021 | 202.18M |
| June 30, 2021 | 204.93M |
| March 31, 2021 | 183.67M |
| December 31, 2020 | 185.86M |
| September 30, 2020 | 188.20M |
| June 30, 2020 | 190.49M |
| Date | Value |
|---|---|
| March 31, 2020 | 200.21M |
| December 31, 2019 | 186.04M |
| September 30, 2019 | 69.33M |
| June 30, 2019 | 70.19M |
| March 31, 2019 | 184.28M |
| December 31, 2018 | 183.02M |
| September 30, 2018 | 205.77M |
| June 30, 2018 | 204.61M |
| March 31, 2018 | 202.53M |
| December 31, 2017 | 201.51M |
| September 30, 2017 | 151.28M |
| June 30, 2017 | 154.38M |
| March 31, 2017 | 152.50M |
| December 31, 2016 | 120.64M |
| September 30, 2016 | 118.81M |
| June 30, 2016 | 116.99M |
| March 31, 2016 | 115.20M |
| December 31, 2015 | 113.43M |
| September 30, 2015 | 115.19M |
| June 30, 2015 | 113.67M |
| March 31, 2015 | 112.17M |
| December 31, 2014 | 110.69M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Viatris, Inc. | 13.51B |
| Liquidia Corp. | 182.90M |
| Elanco Animal Health, Inc. | 3.918B |
| Harmony Biosciences Holdings, Inc. | 158.74M |
| Corcept Therapeutics, Inc. | 7.504M |